Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Heritability enrichment implicates microglia in Parkinson’s disease pathogenesis

Maren Stolp Andersen, Sara Bandres-Ciga, Regina H. Reynolds, John Hardy, Mina Ryten, Lynne Krohn, Ziv Gan-Or, Inge R. Holtman, International Parkinson’s Disease Genomics Consortium, View ORCID ProfileLasse Pihlstrøm
doi: https://doi.org/10.1101/2020.11.25.20238162
Maren Stolp Andersen
1Department of Neurology, Oslo University Hospital, Oslo, Norway
2Institute of Clinical Medicine, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Bandres-Ciga
3Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina H. Reynolds
4Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, United Kingdom
5NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, United Kingdom
6Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Hardy
4Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, United Kingdom
7UK Dementia Research Institute at UCL and Department of Neurodegenerative Disease, UCL Institute of Neurology, University College London, London, UK
8Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK
9UCL Movement Disorders Centre, University College London, London, UK
10Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mina Ryten
4Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, United Kingdom
5NIHR Great Ormond Street Hospital Biomedical Research Centre, University College London, London, United Kingdom
6Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynne Krohn
11Montreal Neurological Institute, McGill University, Montreal, Canada
12Department of Human Genetics, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ziv Gan-Or
11Montreal Neurological Institute, McGill University, Montreal, Canada
12Department of Human Genetics, McGill University, Montreal, Canada
13Department of Neurology and Neurosurgery, McGill University, Montreal, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge R. Holtman
14Department of Biomedical Sciences of Cells & Systems, Section Molecular Neurobiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lasse Pihlstrøm
1Department of Neurology, Oslo University Hospital, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lasse Pihlstrøm
  • For correspondence: lasse.pihlstrom@medisin.uio.no
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Understanding how different parts of the immune system contribute to pathogenesis in Parkinson’s disease is a burning challenge with important therapeutic implications. We studied enrichment of common variant heritability for Parkinson’s disease stratified by immune and brain cell types.

Methods We used summary statistics from the most recent meta-analysis of genome-wide association studies in Parkinson’s disease and partitioned heritability using linkage disequilibrium score regression, stratified for specific cell types as defined by open chromatin regions. We also validated enrichment results using a polygenic risk score approach and intersected disease-associated variants with epigenetic data and expression quantitative loci to nominate and explore a putative microglial locus.

Results We found significant enrichment of Parkinson’s disease risk heritability in open chromatin regions of microglia and monocytes. Genomic annotations overlapped substantially between these two cell types, and only the enrichment signal for microglia remained significant in a joint model. We present evidence suggesting P2RY12, a key microglial gene and target for the anti-thrombotic agent clopidogrel, as the likely driver of a significant Parkinson’s disease association signal on chromosome 3.

Interpretation Our results provide further support for the importance of immune mechanisms in PD pathogenesis, highlight microglial dysregulation as a contributing etiological factor and nominate a targetable microglial gene candidate as a pathogenic player. Immune processes can be modulated by therapy, with potentially important clinical implications for future treatment in Parkinson’s disease.

Competing Interest Statement

Dr. Pihlstrom reports grants from Norwegian Health Association, from South-Eastern Regional Health Authority, Norway, during the conduct of the study. Dr. Gan-Or reports personal fees from Idorsia, Neuron23, Handl Therapeutics, Lysosomal Therapeutics Inc., Deerfield, Lighthouse, Prevail Therapeutics, Ono Therapeutics, Denali, and Inception Sciences outside the submitted work. Other authors have nothing to report.

Funding Statement

MSA was funded by a grant from the South-Eastern Regional Health Authority, Norway. LP is supported by the Norwegian Health association. JH was supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK. JH is also supported by the Medical Research Council (award number MR/N026004/1), Wellcome Trust Hardy (award number 202903/Z/16/Z), the Dolby Family Fund, National Institute for Health Research University College London Hospitals Biomedical Research Centre and BRCNIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Norwegian Regional Committee for Medical and Health Research Ethics REK 30552

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • A full list of IPDGC members is listed at www.pdgeneetics.org/partners

Data Availability

Summary statistics for the dataset excluding participants from 23andMe are available at https://bit.ly/2ofzGrk. The full GWAS summary statistics for the 23andMe discovery data set will be made available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit https://research.23andme.com/dataset-access/ for more information and to apply to access the data.

https://bit.ly/2ofzGrk

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 29, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Heritability enrichment implicates microglia in Parkinson’s disease pathogenesis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Heritability enrichment implicates microglia in Parkinson’s disease pathogenesis
Maren Stolp Andersen, Sara Bandres-Ciga, Regina H. Reynolds, John Hardy, Mina Ryten, Lynne Krohn, Ziv Gan-Or, Inge R. Holtman, International Parkinson’s Disease Genomics Consortium, Lasse Pihlstrøm
medRxiv 2020.11.25.20238162; doi: https://doi.org/10.1101/2020.11.25.20238162
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Heritability enrichment implicates microglia in Parkinson’s disease pathogenesis
Maren Stolp Andersen, Sara Bandres-Ciga, Regina H. Reynolds, John Hardy, Mina Ryten, Lynne Krohn, Ziv Gan-Or, Inge R. Holtman, International Parkinson’s Disease Genomics Consortium, Lasse Pihlstrøm
medRxiv 2020.11.25.20238162; doi: https://doi.org/10.1101/2020.11.25.20238162

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (419)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)